Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Dan Bongino replies to Kash Patel’s praise following departure announcement: ‘honor of a lifetime’

by admin December 18, 2025
December 18, 2025
Dan Bongino replies to Kash Patel’s praise following departure announcement: ‘honor of a lifetime’

Deputy FBI Director Dan Bongino, who announced on Wednesday that he will be departing from his role in January, later replied to FBI Director Kash Patel, who gave him a glowing review.

‘Dan is the best partner I could’ve asked for in helping restore this FBI. He brought critical reforms to make the organization more efficient, led the successful Summer Heat op, served as the people’s voice for transparency, and delivered major breakthroughs in long unsolved cases like the pipe bomb investigation. And that’s only a small part of the work he went about every single day delivering for America,’ Patel said in a post on X.

‘He not only completed his mission – he far exceeded it. We will miss him but I’m thankful he accepted the call to serve. Our country is better and safer for it,’ Patel added.

Bongino replied, thanking Patel.

‘Thank you my friend, it’s been the honor of a lifetime to serve beside you,’ he wrote.

Bongino, a former Secret Service agent who stepped aside from his work hosting a popular show as a conservative commentator to join the FBI, will depart the federal law enforcement agency less than a year after his swearing-in ceremony, which occurred in March 2025.

Prior to Bongino’s announcement on Wednesday, President Donald Trump said, ‘Dan did a great job,’ noting that he thinks Bongino wants to return to his show.

Attorney General Pam Bondi shared Bongino’s announcement post, commenting, ‘Americans are safer because of @FBIDDBongino’s service. Thank you, Dan.’

This post appeared first on FOX NEWS

previous post
Cleantech Market Forecast: Top Trends for Cleantech in 2026
next post
House approves MTG-sponsored bill to criminalize gender transition treatment for minors

Related Posts

Trump vows to increase trade with India, Pakistan...

May 11, 2025

EPA administrator Zeldin demands return of $20B in...

February 13, 2025

Congress unveils spending plan after Trump calls on...

March 9, 2025

Trump Clashes With Reporter Over Tariffs, Citing Pandemic...

August 1, 2025

DNI Gabbard refers intel officials to DOJ for...

April 24, 2025

Energy chief envisions US nuclear renaissance: restoring ‘pit’...

March 31, 2025

Rosie O’Donnell’s Trump obsession continues unabated from Ireland...

December 7, 2025

White House plans ‘extraordinary’ Holy Week as Trump...

April 14, 2025

Even if Trump secures Ukraine-Russia peace deal, can...

March 12, 2025

Senate Republicans block Democrats’ ‘filthy’ counteroffer as shutdown...

September 20, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved